Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Everett › NPI 1700037801
Hospital

Providence Health & Services-Wa

Providence Health & Services-Wa was paid $62.43M by Medicaid between Jan 2018 and Dec 2024, across 459 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 12% of everything it billed.

33Billing provider infoPROVIDENCE HEALTH & SERVICES-WA
EVERETT, WA 98201
33aNPI1700037801assigned 10/07/2008
33bProvider typeGeneral Acute Care Hospital
28Total paid$62.43M
24GClaims2,025,522
24DCodes billed459
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#10 of 49
Median peer was paid$20.06M
This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018337,072$10.74M
2019338,913$10.38M
2020276,662$8.19M
2021319,398$9.35M
2022283,893$9.00M
2023256,124$8.00M
2024incomplete213,460$6.76M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
96361 Intravenous infusion, hydration; each additional hour 12% 25,121 22,354 $7.78M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.7% 43,539 40,840 $4.82M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 7.5% 63,422 42,501 $4.68M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.1% 52,933 48,553 $4.44M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.0% 50,431 46,650 $4.36M
59025 Fetal non-stress test 6.1% 23,753 12,062 $3.79M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.2% 12,416 12,009 $2.03M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 3.2% 16,104 10,246 $1.98M
70450 Computed tomography, head or brain; without contrast material 2.6% 12,900 12,244 $1.62M
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2.6% 5,998 4,540 $1.60M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.0% 5,201 5,113 $1.25M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.5% 2,158 2,125 $940K
447 more codes
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.5% 28,937 $915K
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.4% 1,703 $855K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.4% 8,299 $845K
77412 1.2% 1,568 $765K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 1.1% 10,389 $699K
71275 Computed tomographic angiography, chest, with contrast material 1.0% 4,323 $643K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.0% 6,987 $628K
29581 <1% 3,687 $570K
76830 Ultrasound, transvaginal <1% 6,506 $560K
70496 <1% 3,218 $553K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,249 $539K
76642 <1% 6,538 $535K
76801 <1% 8,505 $525K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 7,702 $521K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 1,884 $451K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,557 $446K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 5,376 $410K
80053 Comprehensive metabolic panel <1% 87,722 $398K
D2930 Prefabricated stainless steel crown - primary tooth <1% 266 $383K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 6,094 $347K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 6,175 $345K
93971 <1% 3,696 $343K
70551 Magnetic resonance imaging, brain; without contrast material <1% 1,941 $328K
G0378 Hospital observation service, per hour <1% 31,533 $327K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,082 $325K
71046 Radiologic examination, chest; 2 views <1% 13,054 $314K
77067 Screening mammography, bilateral, including computer-aided detection <1% 6,945 $302K
76819 Fetal biophysical profile; without non-stress testing <1% 6,492 $294K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 6,342 $292K
93017 <1% 3,011 $287K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,728 $279K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 4,208 $267K
12001 <1% 1,156 $222K
76770 <1% 2,349 $219K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 6,262 $198K
76536 <1% 2,205 $196K
93970 <1% 1,767 $165K
84484 <1% 32,149 $160K
77386 <1% 387 $159K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 9,110 $152K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 2,584 $148K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 6,168 $138K
76813 <1% 2,963 $133K
41010 <1% 142 $131K
77336 <1% 2,407 $131K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 5,602 $130K
10061 <1% 671 $128K
77066 Tomosynthesis, mammo <1% 4,155 $118K
47562 <1% 53 $116K
72100 <1% 4,879 $112K
78815 Positron emission tomography (PET) for limited area imaging <1% 248 $111K
12002 <1% 585 $110K
93458 <1% 121 $109K
76870 <1% 1,158 $107K
74174 <1% 597 $105K
P9016 Red blood cells, leukocytes reduced, each unit <1% 313 $105K
95811 <1% 269 $103K
73562 <1% 2,942 $103K
72141 <1% 698 $99K
87040 <1% 13,964 $91K
12011 <1% 434 $90K
80048 Basic metabolic panel (calcium, ionized) <1% 20,242 $88K
77065 Tomosynthesis, mammo <1% 2,802 $87K
76937 <1% 2,175 $87K
73610 <1% 4,790 $87K
73630 <1% 4,703 $85K
73130 <1% 4,821 $84K
73030 <1% 5,380 $84K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,523 $84K
72040 <1% 2,654 $71K
70498 <1% 3,424 $69K
72125 Computed tomography, cervical spine; without contrast material <1% 6,102 $69K
70491 <1% 578 $68K
74018 <1% 3,214 $68K
83605 <1% 13,981 $67K
76818 <1% 1,098 $67K
19083 <1% 91 $65K
76882 <1% 916 $65K
58571 <1% 26 $64K
73110 <1% 3,455 $63K
70486 <1% 2,289 $62K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 220 $59K
71250 <1% 1,132 $57K
73140 <1% 2,050 $57K
97162 <1% 1,814 $55K
77063 Screening digital breast tomosynthesis, bilateral <1% 6,244 $53K
J1756 Injection, iron sucrose, 1 mg <1% 2,053 $53K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,346 $52K
90715 <1% 2,818 $50K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 40,381 $50K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 51,098 $50K
73502 <1% 2,925 $45K
64483 <1% 95 $45K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 6,279 $43K
83880 <1% 7,847 $41K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 6,416 $41K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 214 $39K
29848 <1% 28 $37K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 3,314 $37K
77334 <1% 123 $37K
36415 Collection of venous blood by venipuncture <1% 51,096 $36K
97116 <1% 2,457 $36K
D2330 <1% 61 $35K
10060 <1% 159 $35K
71045 Radiologic examination, chest; single view <1% 32,719 $34K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,746 $34K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,476 $33K
73560 <1% 1,702 $32K
36430 <1% 747 $32K
87631 <1% 1,562 $31K
72131 <1% 858 $29K
85379 <1% 5,336 $28K
58661 <1% 12 $27K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 82,779 $27K
97165 <1% 775 $26K
36902 <1% 39 $25K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 177 $25K
93880 <1% 495 $24K
73590 <1% 1,990 $24K
J1644 Injection, heparin sodium, per 1000 units <1% 14,294 $23K
87510 <1% 3,120 $23K
58671 <1% 12 $22K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 37 $22K
73080 <1% 1,673 $22K
77290 <1% 89 $22K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 66 $22K
73564 <1% 3,021 $22K
36561 <1% 24 $21K
97166 <1% 777 $19K
54161 <1% 15 $19K
29125 <1% 86 $19K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 105 $19K
85027 <1% 26,071 $19K
84112 <1% 2,473 $19K
97535 Self-care/home management training, each 15 minutes <1% 1,429 $18K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,005 $17K
94770 <1% 225 $17K
84145 <1% 1,641 $17K
96367 <1% 683 $17K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,594 $17K
73090 <1% 1,431 $16K
87660 <1% 3,119 $16K
97161 <1% 533 $16K
93922 <1% 325 $15K
58558 <1% 12 $13K
96375 Therapeutic injection; each additional sequential IV push <1% 27,388 $13K
71271 <1% 130 $12K
D3220 Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction <1% 200 $12K
62323 <1% 47 $12K
77280 <1% 65 $12K
88307 <1% 662 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,386 $11K
93325 <1% 162 $9K
86850 <1% 5,850 $9K
86900 <1% 7,791 $9K
94726 <1% 327 $8K
71101 <1% 614 $8K
94729 <1% 414 $8K
72072 <1% 563 $8K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 248 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 13,637 $8K
72170 <1% 1,657 $8K
80061 Lipid panel <1% 1,761 $7K
84703 <1% 18,409 $7K
81001 <1% 48,358 $7K
73660 <1% 257 $7K
83036 Hemoglobin; glycosylated (A1C) <1% 3,085 $7K
D2332 <1% 14 $7K
72070 <1% 248 $7K
80143 <1% 710 $7K
83735 <1% 10,655 $6K
72110 <1% 172 $6K
94060 <1% 154 $6K
C8908 Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral <1% 25 $6K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 60 $6K
74019 <1% 230 $6K
P9047 Infusion, albumin (human), 25%, 50 ml <1% 15 $5K
99214 Doctor's office visit, returning patient (more involved) <1% 136 $5K
84702 <1% 5,986 $5K
86901 <1% 8,708 $5K
86923 <1% 434 $5K
0001A <1% 138 $5K
97597 <1% 104 $5K
99213 Doctor's office visit, returning patient (routine) <1% 115 $5K
95819 <1% 39 $5K
93308 <1% 31 $5K
83690 <1% 25,496 $4K
80179 <1% 2,066 $4K
85610 <1% 43,178 $4K
84443 Thyroid stimulating hormone (TSH) <1% 4,717 $4K
74183 <1% 13 $4K
G0249 Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests <1% 148 $4K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 12 $4K
93990 <1% 93 $4K
80164 <1% 500 $3K
77049 <1% 16 $3K
73552 <1% 343 $3K
87081 <1% 2,115 $3K
70487 <1% 25 $3K
83050 <1% 491 $3K
82075 <1% 5,596 $3K
93925 <1% 39 $3K
72158 <1% 27 $3K
72197 <1% 12 $3K
86140 <1% 3,941 $3K
82565 <1% 3,043 $3K
96376 <1% 10,330 $3K
29515 <1% 12 $3K
J1750 Injection, iron dextran, 50 mg <1% 73 $3K
75574 <1% 12 $3K
82247 <1% 5,263 $3K
84163 <1% 216 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,476 $2K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,808 $2K
82962 <1% 12,031 $2K
77307 <1% 12 $2K
77002 <1% 17 $2K
72128 <1% 179 $2K
Q3014 Telehealth originating site facility fee <1% 86 $2K
77300 <1% 53 $2K
73120 <1% 71 $2K
82550 <1% 2,857 $2K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 8,205 $2K
80050 General health panel <1% 575 $2K
96368 <1% 14 $2K
73620 <1% 71 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,195 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 34,507 $2K
87070 <1% 2,874 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 31,441 $2K
93926 <1% 26 $2K
82077 <1% 4,505 $2K
81025 <1% 6,364 $2K
85014 <1% 4,027 $2K
99381 <1% 24 $2K
93321 <1% 13 $2K
97163 <1% 57 $2K
82570 <1% 1,910 $2K
76820 <1% 63 $2K
87480 <1% 3,120 $2K
73070 <1% 69 $1K
93797 <1% 180 $1K
76942 <1% 53 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 3,086 $1K
87075 <1% 1,265 $1K
73522 <1% 64 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 22,421 $1K
84466 <1% 583 $1K
97035 <1% 252 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 13,121 $1K
99152 <1% 3,408 $1K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 12 $1K
J3490 Unclassified drugs <1% 3,155 $1K
73100 <1% 32 $1K
82607 <1% 398 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 20,662 $1K
85018 <1% 3,780 $1K
80178 <1% 151 $1K
82731 <1% 98 $1K
93350 <1% 14 $1K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 14,714 $1K
84156 <1% 2,063 $1K
A9270 Non-covered item or service <1% 23,762 $1K
90686 <1% 122 $998.20
87186 <1% 3,100 $998.05
J2704 Injection, propofol, 10 mg <1% 12,783 $966.27
73060 <1% 135 $958.59
93976 <1% 12 $955.19
80076 <1% 268 $942.24
87077 <1% 3,096 $880.18
99204 Doctor's office visit, new patient (more involved) <1% 12 $875.83
74022 <1% 243 $865.16
99153 Mod sedat endo service >5yrs <1% 3,251 $861.39
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,811 $859.99
J7030 Infusion, normal saline solution , 1000 cc <1% 24,443 $843.94
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 11,855 $798.30
87506 <1% 12 $793.94
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 359 $788.77
G0379 Direct admission of patient for hospital observation care <1% 105 $783.17
87205 <1% 3,197 $777.18
73600 <1% 27 $756.62
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 13,731 $742.89
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,530 $725.13
87147 <1% 1,394 $691.37
73700 <1% 14 $642.33
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 2,511 $633.75
83540 <1% 655 $631.71
36591 <1% 381 $626.67
85651 <1% 1,665 $622.09
84439 <1% 549 $621.10
C1769 Guide wire <1% 3,625 $574.59
82728 <1% 339 $569.16
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 26,153 $568.14
84550 <1% 1,285 $560.78
J2270 Injection, morphine sulfate, up to 10 mg <1% 12,840 $550.94
J2785 Injection, regadenoson, 0.1 mg <1% 1,549 $539.00
85049 <1% 964 $514.67
77012 <1% 12 $453.78
85652 <1% 1,096 $444.27
85730 <1% 2,965 $442.46
81003 <1% 3,710 $439.18
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,087 $439.18
J2310 Injection, naloxone hydrochloride, per 1 mg <1% 77 $416.67
72220 <1% 24 $409.44
97803 <1% 30 $403.78
J7120 Ringers lactate infusion, up to 1000 cc <1% 10,444 $403.29
90839 <1% 3,872 $400.17
A9585 Injection, gadobutrol, 0.1 ml <1% 4,531 $399.40
0004A <1% 12 $376.80
J0690 Injection, cefazolin sodium, 500 mg <1% 10,595 $365.57
84100 <1% 1,174 $362.73
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 51 $357.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 517 $356.37
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,792 $298.12
80069 <1% 79 $294.20
A4648 Tissue marker, implantable, any type, each <1% 650 $293.25
82805 <1% 728 $291.38
J1650 Injection, enoxaparin sodium, 10 mg <1% 7,640 $287.84
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 239 $286.70
84450 <1% 1,035 $284.21
94644 <1% 123 $280.87
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 5,109 $271.55
J3370 Injection, vancomycin hcl, 500 mg <1% 5,008 $268.11
94150 <1% 29 $266.83
88304 <1% 689 $265.14
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,923 $258.93
72020 <1% 32 $247.72
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 1,130 $223.71
88342 <1% 1,198 $209.82
89051 <1% 571 $209.71
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 4,563 $169.44
87340 <1% 143 $162.67
86336 <1% 255 $151.05
82553 <1% 30 $143.63
82272 <1% 794 $128.29
0353U <1% 530 $127.14
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 5,309 $115.03
70360 <1% 13 $112.74
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 3,661 $111.44
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,518 $106.49
81005 <1% 192 $105.15
88341 <1% 575 $97.78
J1815 Injection, insulin, per 5 units <1% 9,494 $96.11
J1790 Injection, droperidol, up to 5 mg <1% 1,375 $94.22
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 221 $82.27
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 326 $81.37
82010 <1% 1,459 $81.18
83986 <1% 183 $80.31
85576 <1% 180 $77.28
J1953 Injection, levetiracetam, 10 mg <1% 126 $74.21
82248 <1% 97 $66.26
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 3,983 $65.81
J2060 Injection, lorazepam, 2 mg <1% 7,459 $64.62
J3486 Injection, ziprasidone mesylate, 10 mg <1% 630 $64.50
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,420 $60.07
82803 <1% 326 $57.17
J0780 Injection, prochlorperazine, up to 10 mg <1% 2,712 $55.16
87493 <1% 98 $50.03
85384 <1% 455 $49.39
C1788 Port, indwelling (implantable) <1% 24 $43.14
84132 <1% 171 $42.03
86780 <1% 37 $41.03
82375 <1% 318 $34.03
88108 <1% 209 $33.87
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,995 $31.74
87088 <1% 221 $31.41
J3475 Injection, magnesium sulfate, per 500 mg <1% 2,319 $26.47
82140 <1% 144 $24.38
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 893 $19.28
96040 <1% 1,140 $18.54
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,223 $17.05
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 446 $16.14
87149 <1% 84 $14.57
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 1,041 $12.64
J3480 Injection, potassium chloride, per 2 meq <1% 1,531 $12.40
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 343 $11.59
86706 <1% 14 $11.20
87899 <1% 17 $10.95
J1630 Injection, haloperidol, up to 5 mg <1% 1,930 $9.55
C9113 Injection, pantoprazole sodium, per vial <1% 1,524 $8.93
87045 <1% 15 $8.82
36600 <1% 117 $8.21
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 593 $7.73
J1940 Injection, furosemide, up to 20 mg <1% 1,596 $6.78
J3411 Injection, thiamine hcl, 100 mg <1% 985 $5.88
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 97 $5.39
85347 <1% 595 $5.06
87046 <1% 15 $4.41
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 3,378 $3.63
88311 <1% 13 $2.43
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 2,182 $1.18
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 437 $1.08
J0692 Injection, cefepime hydrochloride, 500 mg <1% 754 $1.02
J3415 Injection, pyridoxine hcl, 100 mg <1% 83 $0.56
J0456 Injection, azithromycin, 500 mg <1% 37 $0.49
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 22,986 $0.01
C1729 Catheter, drainage 0% 51 $0.00
84295 0% 30 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 176 $0.00
D1120 Dental cleaning, child 0% 273 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 431 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 304 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 420 $0.00
0042T 0% 80 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 45 $0.00
C1876 Stent, non-coated/non-covered, with delivery system 0% 30 $0.00
51702 0% 29 $0.00
C1758 Catheter, ureteral 0% 50 $0.00
G0390 Trauma response team associated with hospital critical care service 0% 13 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 0% 13 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 24 $0.00
82947 0% 27 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 49 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 236 $0.00
87641 0% 26 $0.00
C1776 Joint device (implantable) 0% 12 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 154 $0.00
85390 0% 178 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 154 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 791 $0.00
S2900 Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) 0% 161 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 119 $0.00
D0240 0% 295 $0.00
D0272 Bitewings - two radiographic images 0% 297 $0.00
0240U 0% 740 $0.00
J7999 Compounded drug, not otherwise classified 0% 1,527 $0.00
J1836 Injection, metronidazole, 10 mg 0% 536 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 14 $0.00
J3360 Injection, diazepam, up to 5 mg 0% 15 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 124 $0.00
S9981 Medical records copying fee, administrative 0% 15 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 25 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 0% 221 $0.00
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals 0% 101 $0.00
D0150 Comprehensive oral evaluation - new or established patient 0% 95 $0.00
C1781 Mesh (implantable) 0% 127 $0.00
82435 0% 29 $0.00
L8699 Prosthetic implant, not otherwise specified 0% 16 $0.00
J8540 Dexamethasone, oral, 0.25 mg 0% 35 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 29 $0.00
J0280 Injection, aminophyllin, up to 250 mg 0% 29 $0.00
S9982 Medical records copying fee, per page 0% 15 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 0% 40 $0.00
82330 0% 30 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 15 $0.00
51798 0% 13 $0.00
J2560 Injection, phenobarbital sodium, up to 120 mg 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialANDERSON, DONALD (ASST SECRETARY-ENROLLMENT)
Same official

Other billing entities under ANDERSON, DONALD

Full network →
ProviderLocationPaid
Providence Health & Services WashingtonAnchorage, AK$161.45M
Kadlec Regional Medical CenterRichland, WA$151.60M
Swedish EdmondsEdmonds, WA$30.06M
ST. Joseph Health Northern California, LLCEureka, CA$28.68M
Providence Health System Southern CaliforniaTorrance, CA$27.29M
Providence Health System - Southern CaliforniaSan Pedro, CA$24.26M
Providence Health & Services - WashingtonTukwila, WA$21.98M
Swedish Health ServicesSeattle, WA$21.06M
Providence Health & Services WashingtonKodiak, AK$11.39M
Swedish Health ServicesSeattle, WA$11.08M
ST. Joseph Health Northern California, LLCFortuna, CA$8.55M
Collabria CareNapa, CA$8.20M
Providence Health & Services OregonSeaside, OR$8.01M
Providence Health & Services- WashingtonSpokane, WA$8.01M
Hospice of Lubbock INCLubbock, TX$6.48M
Providence Saint John's Health CenterSanta Monica, CA$5.52M
Methodist Hospital LevellandLevelland, TX$4.55M
Collabria CareNapa, CA$4.05M
Methodist Hospital LevellandLevelland, TX$4.01M
Methodist Hospital Plainview TexasPlainview, TX$4.00M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.